Pfizer Inc Asset Turnover Ratio (PFE), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Pfizer Inc  (NYSE: PFE)
 

Pfizer Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Pfizer Inc asset turnover ratio, the ability of Pfizer Inc's assets to generate revenue in the second quarter 2026, increased sequentially to 0.31 in the second quarter (Jun 28 2026), yet the ratio remained below the average, as PFE's position remain challenging.

Within sector 111 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2583 to 2650.

Asset Turnover Ratio Definition



PFE Asset Turnover Ratio (Jun 28 2026)
II. Quarter
(Mar 29 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 28 2025)
III. Quarter
(Jun 29 2025)
II. Quarter
Y / Y Asset Change -1.14 % 0.58 % -1.69 % -4.9 % -4.67 %
Y / Y Revenue Change 2.6 % 5.37 % -1.16 % -5.92 % 10.31 %
Asset Turnover Ratio (TTM) 0.31 0.3 0.3 0.3 0.3
PFE's Total Ranking # 2650 # 2583 # 2405 # 2483 # 1680
Seq. Asset Change -2.63 % -0.26 % 0.5 % 1.28 % -0.93 %
Seq. Revenue Change 4.03 % -17.69 % 5.42 % 13.66 % 6.84 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 112
Healthcare Sector # 373
Overall Market # 2650

Asset Turnover Ratio Statistics
High Average Low
7.83 5.19 3.74
(Apr 03 2022)   (Sep. 30, 2009)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 28 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 28 2026 Assets at quarter ending Jun 28 2026
Vivos Therapeutics Inc   0.85 $ 21.135  Millions$ 24.996  Millions
Alpha Pro Tech Ltd   0.84 $ 62.204  Millions$ 74.083  Millions
Healthlynked Corp  0.82 $ 1.372  Millions$ 1.671  Millions
West Pharmaceutical Services Inc   0.80 $ 3,326.900  Millions$ 4,140.500  Millions
Davita Inc   0.80 $ 14,009.646  Millions$ 17,561.212  Millions
Airsculpt Technologies Inc   0.79 $ 150.724  Millions$ 189.626  Millions
Nexgel Inc   0.79 $ 11.810  Millions$ 15.032  Millions
Iradimed Corporation  0.76 $ 86.339  Millions$ 113.215  Millions
Lifeward ltd   0.76 $ 21.822  Millions$ 28.622  Millions
Msa Safety Inc  0.76 $ 1,946.916  Millions$ 2,568.362  Millions
Harmony Biosciences Holdings inc   0.75 $ 960.191  Millions$ 1,281.189  Millions
Novocure Limited  0.75 $ 699.193  Millions$ 937.159  Millions
Adapthealth Corp   0.74 $ 3,226.709  Millions$ 4,366.244  Millions
Biomerica Inc   0.73 $ 4.453  Millions$ 6.109  Millions
Tenet Healthcare Corp  0.72 $ 21,812.000  Millions$ 30,243.500  Millions
Neurocrine Biosciences Inc   0.70 $ 3,373.900  Millions$ 4,790.625  Millions
Establishment Labs Holdings Inc   0.70 $ 245.105  Millions$ 349.756  Millions
Quest Diagnostics Inc  0.70 $ 11,560.000  Millions$ 16,508.500  Millions
Jaguar Health Inc   0.70 $ 27.815  Millions$ 39.856  Millions
Pulmonx Corporation  0.70 $ 87.393  Millions$ 125.568  Millions
Gyre Therapeutics Inc   0.70 $ 119.383  Millions$ 171.697  Millions
3m Company  0.69 $ 25,180.000  Millions$ 36,426.000  Millions
Illumina Inc   0.69 $ 4,493.000  Millions$ 6,507.500  Millions
Harrow Inc   0.69 $ 274.724  Millions$ 399.729  Millions
Ani Pharmaceuticals Inc  0.68 $ 978.379  Millions$ 1,441.153  Millions
Immucell Corporation  0.67 $ 29.777  Millions$ 44.750  Millions
Guardant Health Inc   0.66 $ 1,183.105  Millions$ 1,779.508  Millions
U S Physical Therapy Inc  0.66 $ 812.203  Millions$ 1,222.803  Millions
Resmed Inc   0.66 $ 5,628.170  Millions$ 8,558.245  Millions
Anika Therapeutics Inc   0.65 $ 121.370  Millions$ 185.642  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.